Evidence map›Paper›PMID 41155606›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Computational Investigation of the Potential Antileishmanial Mechanism of the Nitroindazole Derivative VATR131.

Omar Casanova-Alvarez, Niurka Mollineda-Diogo, Aliuska Morales-Helguera, Vicente Arán-Redó, Reinaldo Molina-Ruiz, Norberto Sánchez-Cruz, Yendrek Velásquez-López, Yunierkis Perez-Castillo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Omar Casanova-AlvarezComputational Chemogenomics Group, Department of Physical Chemistry, Merida Research Unit, Institute of Chemistry, National Autonomous University of Mexico (UNAM), Mérida 97302, Mexico.ORCID 0000-0003-2653-8856
Niurka Mollineda-DiogoCentro de Bioactivos Químicos, Universidad Central "Marta Abreu" de Las Villas, Santa Clara 54800, Cuba.ORCID 0000-0001-5137-0253
Aliuska Morales-HelgueraCentro de Bioactivos Químicos, Universidad Central "Marta Abreu" de Las Villas, Santa Clara 54800, Cuba.
Vicente Arán-RedóInstituto de Química Médica del Consejo Superior de Investigaciones Científicas de España, Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-3390-7157
Reinaldo Molina-RuizCentro de Bioactivos Químicos, Universidad Central "Marta Abreu" de Las Villas, Santa Clara 54800, Cuba.ORCID 0000-0001-5098-5432
Norberto Sánchez-CruzComputational Chemogenomics Group, Department of Physical Chemistry, Merida Research Unit, Institute of Chemistry, National Autonomous University of Mexico (UNAM), Mérida 97302, Mexico.ORCID 0000-0003-2707-3966
Yendrek Velásquez-LópezDepartamento de Procesos Químicos, Alimentos y Biotecnología, Facultad de Ingeniería y Ciencias Aplicadas, Universidad Técnica de Manabí, Av. Urbina y Che Guevara, Portoviejo 130104, Ecuador.ORCID 0000-0002-5871-7106
Yunierkis Perez-CastilloGrupo de Bio-Quimioinformática and Facultad de Ingeniería y Ciencias Aplicadas, Universidad de Las Américas, Quito 170125, Ecuador.ORCID 0000-0002-3710-0035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

leishmanicidal activitymolecular dockingmolecular dynamicsneglected tropical diseasenitroindazole

Identifiers

PMID41155606
PMCPMC12567055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.